Chemokines and atherosclerosis

Area of Science:

• Cardiovascular Biology
• Immunology
• Molecular Medicine

Background:

• Atherosclerosis is an inflammatory disease involving leukocyte accumulation in vessel walls.
• Chemokines are polypeptides that attract cells to inflammatory sites via G-protein coupled receptors.
• These molecules play critical roles in various physiological and pathological conditions, including atherosclerosis.

Purpose of the Study:

• To explore the role of chemokines in the development and progression of atherosclerosis.
• To identify specific chemokines involved in leukocyte trafficking and retention within atherosclerotic plaques.
• To assess the potential of chemokines and their receptors as clinical markers and therapeutic targets for atherosclerosis.

Main Methods:

• Review of in vivo and in vitro investigations on chemokine function in inflammation.
• Analysis of studies examining the expression and function of specific chemokines (e.g., MCP-1, RANTES, CXCL16) in atherosclerosis.
• Examination of research on viral chemokine homologues and their potential role in pathogenesis.

Main Results:

• Chemokines like MCP-1, MCP-4, MIP-1, and RANTES mediate leukocyte recruitment and retention in atherosclerotic plaques.
• CXCL16 exhibits a dual role as both a chemokine and a scavenger receptor.
• Viral chemokine homologues may contribute to atherosclerosis pathogenesis.
• Chemokine expression levels and gene polymorphisms show potential as clinical markers for cardiovascular diseases.

Conclusions:

• Chemokines are key mediators of leukocyte trafficking in atherosclerosis.
• Targeting chemokine signaling pathways presents a viable anti-atherogenic therapeutic strategy.
• Chemokines and their receptors hold promise as biomarkers for cardiovascular disease risk and progression.